These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12622281)

  • 1. Oral manifestations of erythema multiforme.
    Ayangco L; Rogers RS
    Dermatol Clin; 2003 Jan; 21(1):195-205. PubMed ID: 12622281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythema multiforme: integrating the superfluous diagnosis to a veracious conclusion (case report).
    Mounica IL; Tejaswi K; Chennaiah T; Thanmai JV
    Pan Afr Med J; 2020; 37():129. PubMed ID: 33425162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review.
    Yager JA
    Vet Dermatol; 2014 Oct; 25(5):406-e64. PubMed ID: 24990284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes.
    Assier H; Bastuji-Garin S; Revuz J; Roujeau JC
    Arch Dermatol; 1995 May; 131(5):539-43. PubMed ID: 7741539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mucosal diseases: erythema multiforme.
    Scully C; Bagan J
    Br J Oral Maxillofac Surg; 2008 Mar; 46(2):90-5. PubMed ID: 17767983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal disease series. Number IV. Erythema multiforme.
    Farthing P; Bagan JV; Scully C
    Oral Dis; 2005 Sep; 11(5):261-7. PubMed ID: 16120111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythema multiforme. A heterogeneous pathologic phenotype].
    Carrozzo M; Togliatto M; Gandolfo S
    Minerva Stomatol; 1999 May; 48(5):217-26. PubMed ID: 10434539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome: case presentation.
    Donta-Bakoyianni K; Mitsea AG; Deodoropoulou-Papadimitriou K
    J Clin Pediatr Dent; 2002; 27(1):71-6. PubMed ID: 12413176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H; Ohtoshi S; Nakada T; Iijima M
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoplakin I/II immunohistochemical staining may be a helpful tool in differentiating cutaneous graft versus host disease from the erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis spectrum disorders.
    Irwin T; Yeung CCS; Shinohara MM
    J Cutan Pathol; 2024 Jan; 51(1):76-82. PubMed ID: 37691139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema multiforme: a literature review and case report.
    Krippaehne JA; Montgomery MT
    Spec Care Dentist; 1992; 12(3):125-30. PubMed ID: 1440131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
    Akintayo RO; Olarinoye GM; Akintayo FC; Ilesanmi ON
    Acta Dermatovenerol Croat; 2019 Sep; 27(3):200-201. PubMed ID: 31542069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome.
    Léauté-Labrèze C; Lamireau T; Chawki D; Maleville J; Taïeb A
    Arch Dis Child; 2000 Oct; 83(4):347-52. PubMed ID: 10999875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes.
    Huff JC; Weston WL; Tonnesen MG
    J Am Acad Dermatol; 1983 Jun; 8(6):763-75. PubMed ID: 6345608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical factors differentiating erythema multiforme majus from Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
    Watanabe R; Watanabe H; Sotozono C; Kokaze A; Iijima M
    Eur J Dermatol; 2011; 21(6):889-94. PubMed ID: 21873140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM; Brakman M; Maartense E; Bril H; Bakker-Wensveen CA; Bavinck JN
    Ned Tijdschr Geneeskd; 2003 Oct; 147(43):2089-94. PubMed ID: 14619195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
    Niemeijer IC; van Praag MC; van Gemund N
    Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythema multiforme.
    Tonnesen MG; Soter NA
    J Am Acad Dermatol; 1979 Oct; 1(4):357-64. PubMed ID: 512083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.